These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 29027005)

  • 1. Utility of the revised Edmonton Symptom Assessment System (ESAS-r) and the Patient-Reported Functional Status (PRFS) in lung cancer patients.
    Yogananda MN; Muthu V; Prasad KT; Kohli A; Behera D; Singh N
    Support Care Cancer; 2018 Mar; 26(3):767-775. PubMed ID: 29027005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Impact of Baseline Edmonton Symptom Assessment Scale Scores on Treatment and Survival in Patients With Advanced Non-small-cell Lung Cancer.
    McGee SF; Zhang T; Jonker H; Laurie SA; Goss G; Nicholas G; Albaimani K; Wheatley-Price P
    Clin Lung Cancer; 2018 Jan; 19(1):e91-e99. PubMed ID: 28666762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrating Patient-Reported Outcomes Into Prognostication in Gastroesophageal Cancer: Results of a Population-Based Retrospective Cohort Analysis.
    Baccili Cury Megid T; Sharma D; Baskurt Z; Xiaolu Ma L; Wang X; Barron CC; Jang RW; Chen EX; Swallow CJ; Mesci A; Yeung J; Wong RKS; Brar SS; Veit-Haibach P; Kim J; Bach Y; Aoyama H; Elimova E
    Oncologist; 2024 Apr; 29(4):316-323. PubMed ID: 38431782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association between malnutrition risk and revised Edmonton Symptom Assessment System (ESAS-r) scores in an adult outpatient oncology population: a cross-sectional study.
    McLay K; Stonewall N; Forbes L; Peters C
    J Patient Rep Outcomes; 2024 Jul; 8(1):71. PubMed ID: 38995461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of neoadjuvant versus adjuvant chemotherapy for breast cancer patients prior to receiving radiation therapy using Edmonton Symptom assessment system (ESAS) scores.
    Akkila S; Shariati S; Milton L; Behroozian T; Zhang L; Lou J; Lam E; Wong G; Karam I; Chow E
    Support Care Cancer; 2023 Mar; 31(4):236. PubMed ID: 36971851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Province-Wide Analysis of Patient-Reported Outcomes for Stage IV Non-Small Cell Lung Cancer.
    Tjong MC; Doherty M; Tan H; Chan WC; Zhao H; Hallet J; Darling G; Kidane B; Wright FC; Mahar A; Davis LE; Delibasic V; Parmar A; Mittmann N; Coburn NG; Louie AV
    Oncologist; 2021 Oct; 26(10):e1800-e1811. PubMed ID: 34216415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a French Version of the Edmonton Symptom Assessment System-Revised: A Pilot Study of Palliative Care Patients' Perspectives.
    Nekolaichuk C; Huot A; Gratton V; Bush SH; Tarumi Y; Watanabe SM
    J Palliat Med; 2017 Sep; 20(9):966-976. PubMed ID: 28448236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of the Japanese Version of the Edmonton Symptom Assessment System-Revised.
    Yokomichi N; Morita T; Nitto A; Takahashi N; Miyamoto S; Nishie H; Matsuoka J; Sakurai H; Ishihara T; Mori M; Tarumi Y; Ogawa A
    J Pain Symptom Manage; 2015 Nov; 50(5):718-23. PubMed ID: 26169339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of automated screening with Edmonton Symptom Assessment System (ESAS) on health-related quality of life, supportive care needs, and patient satisfaction with care in 268 ambulatory cancer patients.
    Diplock BD; McGarragle KMC; Mueller WA; Haddad S; Ehrlich R; Yoon DA; Cao X; Al-Allaq Y; Karanicolas P; Fitch MI; Myers J; Mitchell AJ; Ellis JWM
    Support Care Cancer; 2019 Jan; 27(1):209-218. PubMed ID: 29931490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishing Cutoff Points for Defining Symptom Severity Using the Edmonton Symptom Assessment System-Revised Japanese Version.
    Yamaguchi T; Morita T; Nitto A; Takahashi N; Miyamoto S; Nishie H; Matsuoka J; Sakurai H; Ishihara T; Tarumi Y; Ogawa A
    J Pain Symptom Manage; 2016 Feb; 51(2):292-7. PubMed ID: 26598039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of the Edmonton Symptom Assessment System in Korean patients with cancer.
    Kwon JH; Nam SH; Koh S; Hong YS; Lee KH; Shin SW; Hui D; Park KW; Yoon SY; Won JY; Chisholm G; Bruera E
    J Pain Symptom Manage; 2013 Dec; 46(6):947-56. PubMed ID: 23628516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modified Edmonton Symptom Assessment System including constipation and sleep: validation in outpatients with cancer.
    Hannon B; Dyck M; Pope A; Swami N; Banerjee S; Mak E; Bryson J; Rodin G; Ridley J; Lo C; Le LW; Zimmermann C
    J Pain Symptom Manage; 2015 May; 49(5):945-52. PubMed ID: 25523890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality of life assessment in advanced non-small-cell lung cancer patients undergoing an accelerated radiotherapy regimen: report of ECOG study 4593. Eastern Cooperative Oncology Group.
    Auchter RM; Scholtens D; Adak S; Wagner H; Cella DF; Mehta MP
    Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1199-206. PubMed ID: 11483329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Italian version of the Edmonton Symptom Assessment System (ESAS)-Total Care (TC): development and psychometric validation in patients undergoing cancer treatment or follow-up.
    Ripamonti C; Leporati R; De Feo G; Di Pede P; Toffolatti L; Guglielmo M; La Carpia D; Miccinesi G; Chiesi F
    Support Care Cancer; 2022 Mar; 30(3):1923-1933. PubMed ID: 34623487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Optimal Cutoff Point for Expressing Revised Edmonton Symptom Assessment System Scores as Binary Data Indicating the Presence or Absence of Symptoms.
    Kako J; Kobayashi M; Kanno Y; Ogawa A; Miura T; Matsumoto Y
    Am J Hosp Palliat Care; 2018 Nov; 35(11):1390-1393. PubMed ID: 29734814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pre-screening of patient-reported symptoms using the Edmonton Symptom Assessment System in outpatient palliative cancer care.
    Lee G; Kim HS; Lee SW; Park YR; Kim EH; Lee B; Hu YJ; Kim KA; Kim D; Cho HY; Kang B; Choi HJ
    Eur J Cancer Care (Engl); 2020 Nov; 29(6):e13305. PubMed ID: 33016473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient-reported symptoms before palliative radiotherapy predict survival differences.
    Nieder C; Kämpe TA; Pawinski A; Dalhaug A
    Strahlenther Onkol; 2018 Jun; 194(6):533-538. PubMed ID: 29344766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of the Edmonton Symptom Assessment Scale.
    Chang VT; Hwang SS; Feuerman M
    Cancer; 2000 May; 88(9):2164-71. PubMed ID: 10813730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncology Nurses' Attitudes Toward the Edmonton Symptom Assessment System: Results From a Large Cancer Care Ontario Study.
    Green E; Yuen D; Chasen M; Amernic H; Shabestari O; Brundage M; Krzyzanowska MK; Klinger C; Ismail Z; Pereira J
    Oncol Nurs Forum; 2017 Jan; 44(1):116-125. PubMed ID: 27991609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Testing the feasibility of using the Edmonton Symptom Assessment System (ESAS) to assess caregiver symptom burden.
    Tanco K; Vidal M; Arthur J; Delgado Guay M; Hui D; Liu D; Chisholm G; Bruera E
    Palliat Support Care; 2018 Feb; 16(1):14-22. PubMed ID: 28264740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.